6 completed, 5 unknown, 1 active not recruiting, 1 recruiting. 3 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 2, Terminated 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Leukoaraiosis: new trials by email Literature Review of Leukoaraiosis trials Research Report on Leukoaraiosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Whole Day Matters After Stroke (BIG-STEPS) Behaviour- & Imaging-Guided Stepping Training Early Post-Stroke (BIG STEPS) intervention - Stroke | Not applicable | Completed | University of Alberta | 55 | 2023-07-10 | 2026-04-13 |
| Predicting the Outcome of ADHD in White Matter Injure Neonates With Multi-modality MRI White Matter Abnormalities, Nonspecific, ADHD | Completed | First Affiliated Hospital Xi'an Jiaotong University | 348 | 2023-01-29 | 2026-09-23 | |
| Using Neuroimaging to Early Diagnose Alzheimer's Disease Through Hippocampal Atrophy Assessment Alzheimer's Disease, Hippocampus | Completed | Centre Hospitalier de Saint-Denis | 85 | 2022-11-24 | 2025-05-11 | |
| Leucoaraiosis and Multimodal MRI With Fingerprinting Technique MRI fingerprinting - Leukoaraiosis, Magnetic Resonance Imaging | Unknown | Lille Catholic University | 250 | 2022-11-14 | 2023-12-26 | |
| Florida Cerebrovascular Disease Biorepository and Genomics Center Cerebrovascular Disease, Ischemic Stroke | Active not recruiting | Mayo Clinic | 72 | 2022-08-02 | 2026-09-03 | |
| Concentration of Trimethylamine Oxide (TMAO) in Blood Plasma as a Risk Factor for Vascular Cerebral Damage Magnetic Resonance Imaging (MRI), Blood samples collection, Neuropsychological tests - Vascular Diseases, Leukoaraiosis | Unknown | Gdansk University of Physical Education and Sport | 300 | 2021-12-30 | 2021-07-20 | |
| MRI Biomarkers for Radiation-Induced Neurocognitive Decline Following SRS of Newly Diagnosed Brain Mets Brain Metastases, Neurocognitive Deficit | Recruiting | UNC Lineberger Comprehensive Cancer Center | 20 | 2019-12-04 | 2026-08-14 | |
| The Evaluation of White Matter Intensities in Patients with Pediatric Epilepsy Epilepsies, White Matter Alterations | Completed | Aysen Orman | 173 | 2019-08-01 | 2025-03-20 | |
| the Effects of Cerebral Collateral Circulation on the Outcome of Leukoaraiosis in High-risk Population Leukoaraiosis | Unknown | Shanghai Zhongshan Hospital | 1037 | 2017-10-11 | 2020-07-07 | |
| Decoding Presymptomatic White Matter Changes in Huntington Disease Brain imaging, Neurological assessments, Psychological assessments - Huntington Disease, White Matter Alterations | Not applicable | Completed | Institut National de la Santé Et de la Recherche Médicale, France | 60 | 2017-07-11 | 2020-02-18 |
| Remote Preconditioning Over Time To Empower Cerebral Tissue Ischemic Preconditioning - Ischemic Stroke, Cerebral Small Vessel Disease | Not applicable | Terminated | University of California, Los Angeles | 6 | 2015-11-01 | 2021-03-10 |
| The Relationship Between White Matter Hyperintensity With Cognition and Emotion Aged, Leukoaraiosis | Unknown | Zhejiang University | 200 | 2014-01-01 | 2017-06-14 | |
| Efficacy Study of Cilostazol and Aspirin on Cerebral Small Vessel Disease aspirin, cilostazol - Cerebral Small Vessel Disease | Phase 4 | Unknown | Inha University Hospital | 255 | 2013-07-17 | 2019-08-08 |
| Intracerebral Hemorrhage Due to Oral Anticoagulants: Prediction of the Risk by Magnetic Resonance oral anticoagulants - Ischemic Stroke | Completed | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 1000 | 2012-04-01 | 2018-08-03 |
Ischemic Stroke (3) · Cerebral Hemorrhage (2) · Cerebral Small Vessel Diseases (2) · Cognitive Dysfunction (2) · Arteriovenous Fistula (1) · Attention Deficit Disorder with Hyperactivity (1) · Brain Ischemia (1) · Brain Neoplasms (1) · CADASIL (1) · Cerebrovascular Disorders (1) · Dementia, Vascular (1) · Epilepsy (1) · Fibromuscular Dysplasia (1) · Hematoma, Subdural (1)
Pathologic Processes (14) · Pathological Conditions, Signs and Symptoms (14) · Nervous System Diseases (10) · Brain Diseases (9) · Central Nervous System Diseases (9) · Cardiovascular Diseases (6) · Cerebrovascular Disorders (5) · Mental Disorders (5) · Vascular Diseases (5) · Neurocognitive Disorders (4) · Cognition Disorders (3) · Stroke (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Dementia (2) · Genetic Diseases, Inborn (2)
Anticoagulants (1) · Aspirin (1) · Cilostazol (1) · Dabigatran (1) · Ischemic Preconditioning (1) · Magnetic Resonance Imaging (1) · Methods (1) · Neuroimaging (1) · Rivaroxaban (1) · Warfarin (1) · apixaban (1) · coumarin (1)
Aysen Orman (1) · Centre Hospitalier de Saint-Denis (1) · First Affiliated Hospital Xi'an Jiaotong University (1) · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1) · Gdansk University of Physical Education and Sport (1) · Inha University Hospital (1) · Institut National de la Santé Et de la Recherche Médicale, France (1) · Lille Catholic University (1) · Mayo Clinic (1) · Shanghai Zhongshan Hospital (1) · UNC Lineberger Comprehensive Cancer Center (1) · University of Alberta (1) · University of California, Los Angeles (1) · Zhejiang University (1)
China (3) · France (3) · United States (3) · Canada (1) · Italy (1) · Poland (1) · South Korea (1) · Spain (1) · Turkey (Türkiye) (1)
Colette J Shen, MD, PhD (1) · James Meschia, MD (1) · Jian Yang, Ph.D.,M.D. (1) · Latisha K Sharma, MD (1) · Robert A Olek, PhD (1) · Seong Hye Choi, MD, PhD (1) · Tong Zhu, PhD, DABR (1) · Victor Ezeugwu, PhD (1) · Xin Wang (1)
PMID 31004066, PMID 31942173, PMID 34781708, PMID 35833913, PMID 38060584